• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

expresspharmaJune 24, 2021

Tag: Dr Reddy’s , Icosapent Ethyl capsules , triglyceride

Dr Reddy’s Laboratories 21st launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.

Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Previous:Turkish COVID-19 vaccine starts phase-III trials

Next:Adroit Biomed develops orally-dissolving mini effervescent tablet to prevent, manage and recover from COVID-19

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides

Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides
Miglyol -812 (triglycerides of capric/caprylic acids)

Miglyol -812 (triglycerides of capric/caprylic acids)
omega-3-acid triglycerides

omega-3-acid triglycerides
Medium chain triglycerides Powder(Coconut oil)

Medium chain triglycerides Powder(Coconut oil)
MCT Oil（Medium Chain Triglycerides）

MCT Oil（Medium Chain Triglycerides）
Medium chain triglycerides Powder(palm oil)

Medium chain triglycerides Powder(palm oil)
Conjugated Linoleic Acid-Triglyceride

Conjugated Linoleic Acid-Triglyceride
Triglyceride

Triglyceride
Medium chain triglyceride microcapsule powder

Medium chain triglyceride microcapsule powder
Omega-3 Triglycerides

Omega-3 Triglycerides

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service